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affinity maturation, and production of memory B cells
and long-lived PCs (Jacob et al., 1991b; MacLennan
and Gray, 1986; McHeyzer-Williams et al., 1991). Post-
GC PCs have extended half-lives (McHeyzer-Williams
and Ahmed, 1999), produce high-affinity antibody, and
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reside preferentially in the bone marrow (Benner et al.,Columbia University College of Physicians
1981). Memory B cells rapidly expand and differentiateand Surgeons
into PCs in response to antigen rechallenge (MacLennanNew York, New York 10032
and Gray, 1986; McHeyzer-Williams et al., 2000). Mem-2 Integrated Program in Cellular, Molecular
ory response PCs produce high-affinity antibodies butand Biophysical Studies
appear to have short life spans (Driver et al., 2001;Columbia University College of Physicians
McHeyzer-Williams et al., 2000).and Surgeons
How each of these PCs develops in vivo remains un-New York, New York 10032
clear. Antigen-driven cell expansion precedes terminal3 Department of Immunology
differentiation in each case and cell cycle arrest is nec-The Scripps Research Institute
essary for terminal PC generation (Tourigny et al., 2002).La Jolla, California 92037
However, as opposed to B cells that become short-lived4 Department of Biochemistry and Molecular Biophysics
PCs, B cells that have been through the GC reactionColumbia University College of Physicians
may differ substantially in their terminal differentiationand Surgeons
path. Two subtypes of nonsecreting memory B cells that
exit the GC (Driver et al., 2001) and respond to antigen
rechallenge (McHeyzer-Williams et al., 2000) have beenSummary
observed. Both populations express somatically mu-
tated BCR with evidence of affinity-based selectionBlimp-1 is a transcriptional repressor able to drive
(McHeyzer-Williams et al., 2000) but differ in cell surfacethe terminal differentiation of B cells into Ig-secreting
phenotype, propensity to form PCs, and proliferativeplasma cells. We have created mice with a B cell-
capacity upon adoptive transfer (McHeyzer-Williams etspecific deletion of prdm1, the gene encoding Blimp-1.
al., 2000). CD138B220 memory B cells produced 25-B cell development and the number of B cells re-
fold more PCs, but 15-fold fewer cells were recoveredsponding to antigen appear to be normal in these mice.
after transfer compared to CD138B220 memory cells.However, in response to either TD or TI antigen, serum
This suggests a linear progression from post-GCIg, short-lived plasma cells, post-GC plasma cells, and
CD138B220 memory B cells to CD138B220 pre-plasma cells in a memory response are virtually ab-
plasma memory B cells to terminally differentiatedsent, demonstrating that Blimp-1 is required for plas-
CD138B220/ PCs; however, there is no genetic evi-macytic differentiation and Ig secretion. In the ab-
dence for a developmental link between these subsets.sence of Blimp-1, CD79bB220 pre-plasma memory
B lymphocyte induced maturation protein-1 (Blimp-1)B cell development is also defective, providing evi-
was initially described as a “master regulator” of plasmadence that this subset is an intermediate in plasma
cell differentiation (Turner et al., 1994). Not only wascell development. B cells lacking Blimp-1 cannot se-
Blimp-1 mRNA induced during differentiation of BCL1crete Ig or induce S mRNA when stimulated ex vivo.
cells to an IgM secreting state, but enforced expressionFurthermore, although prdm1/ B cells fail to induce
of Blimp-1 was sufficient to drive differentiation (Turner
XBP-1, XBP-1 cannot rescue plasmacytic differentia-
et al., 1994). Subsequent studies confirmed that en-
tion without Blimp-1. forced expression of Blimp-1 is sufficient to drive plas-
macytic differentiation of B cells at an appropriate devel-
Introduction opmental stage (Lin et al., 2000, 2002; Piskurich et al.,
2000; Schliephake and Schimpl, 1996; Shaffer et al.,
Plasma cells (PCs), the critical immune effector cells 2002). Furthermore, Blimp-1 is expressed in all PCs and
dedicated to secretion of antigen-specific immunoglob- in a small subset of germinal center B cells that have
ulin (Ig), develop at three distinct stages of antigen- some plasma cell characteristics (Angelin-Duclos et al.,
driven B cell development (Calame, 2001). Short-lived 2000; Falini et al., 2000). These data are all consistent
PCs emerge in response to both thymus-independent with an important role for Blimp-1 in plasma cell differen-
(TI) and thymus-dependent (TD) antigens (Ho et al., 1986) tiation (reviewed in Calame, 2001; Calame et al., 2003).
in the first week after antigen exposure in extrafollicular Blimp-1 is a 98 kDa protein containing five zinc finger
foci of secondary lymphoid organs (Jacob et al., 1991a). motifs, which confer sequence-specific DNA binding
These PCs have half-lives of 3–5 days (Ho et al., 1986) (Keller and Maniatis, 1992; Tunyaplin et al., 2000). The
and secrete unmutated Ig (Jacob et al., 1991b; McHeyzer- protein is a transcriptional repressor that associates
Williams et al., 1993). TD antigens also induce a germinal with hGroucho (Ren et al., 1999) and histone deacety-
center (GC) pathway involving somatic hypermutation, lases (Yu et al., 2000). Functional Blimp-1 binding sites
have been identified on several direct targets including
c-myc, CIITA promoter III, Pax5, SpiB, and Id3 (Lin et*Correspondence: klc1@columbia.edu
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Figure 1. Prdm1flox/flox CD19Cre/ Mice Have Efficient Deletion of prdm1 in B Cells
(A) Strategy for generating an allele of prdm1 with the zinc finger region flanked by LoxP sites (triangles). Part of the endogenous locus,
targeting construct, and floxed allele after in vitro deletion of neo are shown.
(B) Southern blot analysis of B cell DNA to detect deleted and floxed prdm1.
(C) Immunoblots of cell lysates from splenocytes cultured in LPS for 3 days were blotted with mAb to Blimp-1.
al., 1997, 2002; Piskurich et al., 2000; Shaffer et al., 2002). achieve deletion of prdm1 in B cells (Rickert et al., 1997).
CD19 expression is B cell specific, beginning in earlyIn B cells, Blimp-1 regulates three large gene expression
programs: cell cycle arrest, induction of Ig secretion, progenitors and continuing throughout development.
To determine the efficiency of prdm1 deletion in Band inhibition of GC functions (Shaffer et al., 2002).
Although Blimp-1 is sufficient to drive plasmacytic cells, B220 splenocytes were purified from prdm1flox/flox
CD19Cre/ mice and DNA was analyzed by Southern blot-differentiation, it is not known if Blimp-1 is required for
plasmacytic differentiation. Gene targeting is the obvi- ting. There is very efficient deletion of prdm1 in B cells of
the prdm1flox/floxCD19Cre/ mice (Figure 1B). Similar resultsous way to approach this question. However, mice lack-
ing prdm1, the gene encoding Blimp-1, die as early em- were seen using prdm1flox/-CD19Cre/mice (not shown) so
prdm1flox/floxCD19Cre/and prdm1flox/-CD19Cre/ mice werebryos (M. Davis, personal communication). This is
probably because Blimp-1 is expressed in multiple em- used interchangeably. To assess Blimp-1 protein, B220
splenocytes were purified and stimulated ex vivo withbryonic cells, as early as day 7 (Chang and Calame,
2002). Therefore, we created mice in which the exons LPS. Blimp-1 was almost undetectable in B cells from
prdm1flox/floxCD19Cre/ mice although controls showedof prdm1 that encode the zinc finger motifs of Blimp-1
are flanked by LoxP sites. Here we describe the pheno- good expression (Figure 1C). Thus, we conservatively
estimate at least 90% of the mature B cells fromtype of prdm1flox/floxCD19Cre/ mice, which lack prdm1 in
their mature B cells. These mice have normal B cell CD19Cre/prdm1flox/flox mice lack Blimp-1.
development but cannot form PCs or secrete Ig nor-
mally. They are also defective in the formation of pre- Severe Reduction in Ig Secretion and Plasma Cell
plasma memory B cells. Formation in prdm1flox/floxCD19Cre/ Mice
The numbers and developmental subsets of B cells in
the bone marrow and spleen of prdm1flox/floxCD19Cre/Results
mice appeared normal when analyzed by flow cytometry
(not shown); however, serum Ig was significantly re-Conditional Deletion of prdm1
Exons that encode the zinc finger motifs of Blimp-1 were duced in unimmunized mice (Figure 2A). To assess a
TI response, prdm1flox/floxCD19Cre/ and littermate controlflanked with LoxP sites (Figure 1A). Prdm1flox/flox mice
were crossed with mice expressing Cre recombinase mice were immunized with NP-Ficoll. Control mice
showed normal increases in NP-specific serum IgM andunder the control of the CD19 promoter (CD19Cre/) to
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IgG3, but prdm1flox/floxCD19Cre/ mice had a greatly dimin- lived PCs (day 14) was blocked in the absence of
Blimp-1.ished serum Ig response (Figure 2B). NP-specific serum
IgM, IgG1, and IgG2a were determined following immu- In contrast to the depletion of NP PCs, there was an
increase in the frequency (Figure 3B; 31  0.7% andnization with NP-KLH precipitated in alum to study a TD
response. The prdm1flox/floxCD19Cre/ mice showed a very 62  6.4% controls and prdm1flox/floxCD19Cre/ respec-
tively, p  0.004) and total numbers (Figure 3C) oflarge reduction in serum Ig of all 3 isotypes (Figure 2C).
Failure to secrete Ig was also seen in a recall response CD138B220 NPB cells that expressed GL7 (a marker
for GC B cells)(Han et al., 1997) at day 7 comparedelicited by a second immunization with NP-KLH in alum
(Figure 2C). to preimmune animals (negligible numbers of total NP-
specific cells see Figure 3C and NP-specific GL7 cellsELISPOT assays were performed to determine if the
decrease in serum Ig was due to a lack of Ig secreting data not shown). This trend persisted to day 14 with
respect to frequency among total NP cells (32  9%cells in prdm1flox/floxCD19Cre/ mice following immuniza-
tion. In agreement with the decrease in serum IgM, there and 67 10% control and prdm1flox/floxCD19Cre/, respec-
tively, p  0.03) and total numbers (Figure 3C). A similarwas a severe decrease in the number of NP-specific
IgM secreting cells in the prdm1flox/floxCD19Cre/ mice (Fig- increase in total B220GL7 cells was observed in
prdm1flox/floxCD19Cre/ mice from day 3 to 20 followingure 2B, third panel, and 2C, second panel). We also
determined the numbers of CD138 B220/ PCs in the immunization (data not shown) with larger and more
numerous GCs also seen with PNA staining of spleenspleens of the immunized mice. After immunization with
NP-KLH, control mice showed increased numbers of sections (Figure 3E). Thus, B cells lacking Blimp-1 accu-
mulate to higher numbers in the GC compartment with-CD138B220/PCs in a pattern consistent with an early
plasma cell response and a later post-GC response (Fig- out differentiating into long-lived PCs.
In control animals, a third subset of NP B cells isure 2D). However, the prdm1flox/floxCD19Cre/ mice had
very few CD138B220/ PCs at any time (Figure 2D). evident as CD138B220 (Fig3B, second panel). This
memory B cell subset expresses CD79b and not GL7Therefore, while Blimp-1 is not required for B cell matu-
ration, it is required for formation of CD138B220/ im- (data not shown), does not secrete antibody, and has
undergone affinity maturation (Driver et al., 2001). Al-munoglobulin-secreting PCs both early and late in a
primary immune response. It is required for production though not found in the GC, they probably originate
there during the primary response (Driver et al., 2001).of a response to both TI and TD antigens and for serum
Ig in both a primary and recall response. These cells will be referred to as pre-plasma memory B
cells or B220CD79b cells throughout this study. The
majority of NP cells that migrate and persist in the bonePre-Plasma Memory B Cell Formation Is Defective
marrow after priming express the CD138B220CD79bin a Primary Response
phenotype and are also considered pre-plasma memoryA six-color flow cytometric strategy, including antigen
B cells (Figure 3D, upper panels). Thus, bone marrowbinding and cell surface phenotype (Driver et al., 2001;
migration is a reliable indicator of pre-plasma memoryMcHeyzer-Williams et al., 2000), was used to quantify
B cell development. In the absence of Blimp-1, pre-NP subsets following IP immunization with NP-KLH
plasma memory B cells fail to develop fully in the spleen.in Ribi adjuvant. Baseline labeling in spleen and bone
Although some NP cells have lower B220 levels in themarrow before immunization using this strategy is negli-
spleen (Figure 3B, lower middle panel, 3C total num-gible (Figures 3A, 3C, and 3D). As antibody can be cy-
bers), there is 90% reduction in the pre-plasma mem-tophilic and passively adsorb to cells spuriously confer-
ory B cell compartment in the bone marrow on day 7ring antigen binding (Berken and Benacerraf, 1966;
and 95% reduction on day 14 (Figure 3D; day 7 p Boyden, 1960), we transferred NP-immune sera (2 doses
0.02, day 14 p  0.04). Thus, Blimp-1 is required for theof 200 l) into naive mice with no change in NP binding
complete development of pre-plasma memory B cells.(Figures 3A, 3C, and 3D). Thus, no passively adsorbed
antibody in vivo interferes with the cellular quantification
using the strategy presented here. Memory B Cells Require Blimp-1 for Further
Development and Plasma Cell DifferentiationWhen immunized with adjuvant alone, negligible label-
ing was observed (Driver et al., 2001; McHeyzer-Williams The NP memory B cell response 5 days after antigen
rechallenge was also assessed (Figure 4). Total NP-spe-et al., 2000). At day 7, the peak of early clonal expan-
sion (Driver et al., 2001), total NPIgD B cells cific memory B cells were very low on day 42 before
rechallenge; however, a rapid and substantial expansion(also PICD4CD8) were equivalent in control and
prdm1flox/floxCD19Cre/ mice (Figures 3B and 3C, first pan- of NP B cells was seen in both control and prdm1flox/flox
CD19Cre/ mice (Figure 4A, first panels; Figure 4B, panelels). In contrast, there was a 95% reduction in total
CD138B220/ NP PCs in the spleen at day 7 (Figures 1). In contrast, there was a profound alteration in mem-
ory B cell subsets that appeared in the absence of3B and 3C, second panels; Figure 3C; p  0.004). There
was a substantial reduction in NP-specific PCs on day Blimp-1 (Figure 4A, second panels, and 4B, panels 2–4).
Absence of CD138B220/ NP PCs was virtually com-14 in controls but PC numbers in prdm1flox/floxCD19Cre/
mice were still significantly fewer (Figure 3C; 70% reduc- plete with a 99% reduction in total cells (Figure 4A,
second panels; Figure 4B, panel 2). Similar to the primarytion, p  0.05) as well as total CD138 cells in spleen
sections (Figure 3E). Thus, antigen-specific clonal response, the CD138B220NP compartment com-
prised the majority of the memory B cell response inexpansion was not dependent on Blimp-1; however,
consistent with previous results (Figure 2), the develop- the absence of Blimp-1. There were almost 10-fold more
CD138B220NP cells expressing the GC marker, GL7,ment of both short-lived PCs (day 7) and post-GC long-
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Figure 2. Prdm1flox/flox CD19Cre/ Mice Do Not Develop PCs or Secrete Ig
(A) Serum from naive mice was analyzed for resting levels of IgM, IgA, IgG1, IgG2a, IgG2b, and IgG3 by ELISA. Mice were immunized with
NP-Ficoll (B) or NP-KLH (C and D). Serum was analyzed by ELISA for NP-specific IgM and IgG3 (B) or NP-specific IgM, IgG1, and IgG2a (C).
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in the prdm1flox/floxCD19Cre/ mice compared to controls that prdm1/ B cells are defective in induction of Ig
light chain mRNA (A. Shaffer and M.S.-S., unpublished(Figure 4A, third panels, Figure 4B, panel 3). Pre-plasma
memory B cells (CD138B220CD79bNP) were re- data). Thus, both the induction of Ig mRNA and the
switch from M to S mRNA are defective in prdm1/duced 75% in prdm1flox/floxCD19Cre/ spleens (Figure 4B,
p  0.04) and reduced 98% in the bone marrow (p  B cells.
0.006, data not shown).
Thus, the primary GC reaction resolved 42 days after Blimp-1 and XBP-1 Have Separate Roles
in Plasmacytic Differentiationinitial challenge in the prdm1flox/floxCD19Cre/ mice. How-
ever, similar to the primary response, the NP-specific The activator XBP-1 is the only other transcription factor
known to be required specifically for plasmacytic differ-memory response accumulated aberrantly in the
GL7B220NP compartment without producing pre- entiation (Reimold et al., 2001). Splenic B cells lacking
XBP-1 have normal levels of Blimp-1 following ex vivoplasma memory B cells or PCs. Thus, Blimp-1 is clearly
required for normal plasma cell development at all stimulation, demonstrating that Blimp-1 cannot drive
plasmacytic differentiation in the absence of XBP-1 andstages of the primary and memory response.
suggesting that Blimp-1 acts before XBP-1 in plasma
cell development (Reimold et al., 2001). Consistent withPrdm1/ B Cells Cultured Ex Vivo with LPS
Proliferate, but Fail to Induce S mRNA this idea, Blimp-1 can induce XBP-1 mRNA indirectly
by repressing Pax5 (Lin et al., 2002; Shaffer et al., 2002).or Secrete Immunoglobulin
When cultured ex vivo with LPS, murine splenic B cells We analyzed XBP-1 mRNA and protein in B cells lacking
Blimp-1. Semiquantitative RT-PCR showed that XBP-1proliferate and differentiate into Ig-secreting cells. To
assess the proliferative capacity of stimulated B cells mRNA was strongly induced in LPS treated controls,
but not in prdm1/ cells (Figure 6A). Both unprocessedthat lack Blimp-1, prdm1/ and control B220 cells
were cultured with LPS and viable cells were counted. and processed forms of XBP-1 (Calfon et al., 2002; Iwa-
koshi et al., 2003; Lee et al., 2002; Yoshida et al., 2001)At all time points after LPS treatment, there were more
prdm1/ than control cells (Figure 5A). When spleno- were induced in control cultures; however, minimal un-
processed and no processed XBP-1 was detected incytes were labeled with CFSE, after 2 days of LPS treat-
ment, prdm1/ cells had lower CFSE intensity than prdm1/ cultures (Figure 6B). Therefore, B cells without
Blimp-1 fail to induce XBP-1 mRNA normally and arecontrol cells (Figure 5B), indicating that the increased
number of cells in the prdm1/ cultures was due to defective in their ability to make processed XBP-1
protein.increased proliferation. When propidium iodide staining
was performed to quantitate apoptotic cells after stimu- Since XBP-1 is required for plasma cell formation and
because XBP-1 is not induced normally in the absencelation with LPS, no significant difference was observed
in the number of apoptotic cells in prdm1/ and control of Blimp-1, we wondered if the critical role for Blimp-1
in plasmacytic differentiation was solely induction ofcultures (not shown).
To analyze differentiation, secreted Ig and the number XBP-1. To investigate this possibility, LPS treated
prdm1/ splenic B cells were infected with bicistronicof Ig secreting plasma cells was determined in the LPS
cultures. Control B cells secreted large quantities of retroviruses expressing either Blimp-1 or XBP-1 (pro-
cessed form) and YFP. YFP cells were analyzed byIgM and small amounts of IgG3 but prdm1/ B cells
secreted almost no IgM or IgG3 (Figure 5C). Also, there flow cytometry for CD138 expression and by ELISPOT
for IgM secretion. LPS treated prdm1/ cells express-were IgM secreting cells and CD138 cells in the control
cultures, but almost none in the prdm1/ cultures (Fig- ing exogenous Blimp-1 induced surface CD138 and se-
creted IgM, demonstrating that Blimp-1 expressed fromures 5D and 5E). Therefore, even after activation with
LPS, prdm1/ B cells are unable to differentiate into a retrovirus can complement the prdm1/ defect (Fig-
ures 6C and 6D). However, prdm1/ cells infected withCD138 cells or secrete Ig, recapitulating ex vivo the
defects observed in vivo. the XBP-1 virus were not able to induce CD138 or nor-
mally secrete IgM (Figures 6C and 6D). To confirm thatTo investigate the mechanism responsible for the
block in Ig secretion in prdm1/ B cells, IgM protein in functional XBP-1 was present in these cells, semiquanti-
tative RT-PCR was performed on YFP cells to amplifyprdm1/ and control cells was assayed by immunoblot-
ting following culture with LPS. Cell lysates from XBP-1 and DnaJ mRNA. DnaJ expression is activated
by XBP-1 in B cells (Lee et al., 2003). In prdm1/ cellsprdm1/ and control B cells contained similar amounts
of the membrane form of heavy chain (M), but control infected with virus expressing XBP-1, and not in cells
infected with control virus, XBP-1 mRNA was increasedcells had more than 10-fold higher amounts of secreted
 (S) than the prdm1/ cells (Figure 5F). When M (Figure 6E). DnaJ mRNA was also induced in cells ex-
pressing XBP-1 (Figure 6E), providing evidence that theand S mRNA were analyzed by semiquantitative RT-
PCR (Figure 5G), at least a 16 reduction in S mRNA expressed XBP-1 was functional. These experiments
demonstrate that Blimp-1 is fully able to rescue a defi-was observed in prdm1/ B cells. We have also noted
Splenocytes were harvested at indicated days to quantitate NP-specific IgM secreting cells by ELISPOT (B and C). A secondary immunization
with NP-KLH was given at least 6 weeks after priming and serum was analyzed by ELISA for NP-specific IgG1 and IgG2a (C). (D) On indicated
days after NP-KLH, splenocytes were stained for B220 and CD138. Representative CD138 and B220 levels for day 7 post-NP-KLH are shown
for prdm1flox/flox CD19Cre/ and control. The frequency of CD138B220/ cells was determined. Each time point represents the average and
SEM of at least three mice. For all panels, control mice are represented by filled diamonds and prdm1flox/flox CD19Cre/ by open circles.
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Figure 4. Memory B Cell Responses Require
Blimp-1
Mice were immunized with NP-KLH in Ribi,
rested for 6 weeks, and reimmunized with
antigen in adjuvant. Splenocytes harvested
before immunization at day 42 primary and 5
days after antigen recall, stained as de-
scribed in Figure 3. (A) NP and IgD levels of
CD4CD8 PI cells harvested from spleen
on day 5 after recall (first two panels) with
small box insert outlining NPIgD events.
CD138 versus B220 levels on PICD4CD8
NPIgD cells (second two panels). GL7 lev-
els on CD138B220 NP-specific cells (third
two panels), mean frequency  SEM, n  3.
Controls displayed in upper panels and
prdm1flox/flox CD19Cre/ lower panels. Mean
frequency SEM, n 3 across separate ani-
mals. (B) Cell numbers in spleen for each
group at day 42 primary and day 5 memory:
NP-specific cells (PICD4CD8NPIgD),
CD138 cells (NP-specific and CD138
B220/), B220 GL7(NP-specific and
CD138B220GL7), B220CD79b (NP-
specific and CD138B220CD79b). Mean
frequencies  SEM, n  3.
ciency in prdm1, but XBP-1 cannot compensate for a inhibited (Angelin-Duclos et al., 2002). Although previ-
ous studies using cultured B cells treated with antisenselack of Blimp-1. Thus, because XBP-1 is not sufficient
to drive plasmacytic differentiation in the absence of Blimp-1 oligonucleotides suggested that Blimp-1 was
required for TI, but not TD responses (Soro et al., 1999),Blimp-1, Blimp-1 must have other critical targets in plas-
macytic differentiation besides XBP-1. the phenotype of prdm1flox/floxCD19Cre/ mice establishes
a role for Blimp-1 in response to both types of antigens.
Mice lacking Blimp-1 in their B cells were unable toDiscussion
mount a normal humoral response to either a TI antigen
or to the TD form (Figures 2–4). In the TD response,Requirement for Blimp-1 in Plasma Cell
Formation and Ig Secretion both early and post-germinal center responses were
defective, as was a recall response to secondary chal-Blimp-1 is known to be sufficient to drive terminal differ-
entiation of B cells into Ig secreting PCs (Lin et al., 2000, lenge (Figures 2–4). However, some prdm1flox/floxCD19Cre/
mice did have a small number of PCs and/or serum Ig2002; Piskurich et al., 2000; Schliephake and Schimpl,
1996; Shaffer et al., 2002; Turner et al., 1994). The results following immunization. At present we cannot distin-
guish between the possibility that a small fraction of Bpresented here provide unequivocal evidence that
Blimp-1 is also required for plasmacytic differentiation cells did not delete prdm1 or the existence of a minor,
Blimp-1-indepedent pathway for PC differentiation.and Ig secretion. This is consistent with studies where
expression of a blocking form of Blimp-1 inhibited Ig Finding that prdm1/ B cells are hyperproliferative
(Figure 5) confirms a role for Blimp-1 in cell cycle arrestsecretion by B cells cultured ex vivo (Shaffer et al., 2002).
However, mice expressing a blocking form of Blimp-1 and suggests that Blimp-1 is important for limiting the
number of divisions plasmablasts undergo prior to ter-did not have defective plasma cell differentiation, pre-
sumably because endogenous Blimp-1 was not fully minal differentiation. This is consistent with microarray
Figure 3. Prdm1flox/flox CD19Cre/ Mice Have Defective Development of Antigen-Specific PCs and Pre-Plasma Memory B Cells
(A) NP and IgD levels on CD4CD8 PI spleen cells before immunization. Upper panel presents a wt C57BL/6 that had received 2  200 l
NP-immunized serum IV before analysis and lower panel presents prdm1flox/flox CD19Cre/ animals. Inserts outline the region used for estimation
of NPIgD cells with mean frequencies  SEM across three separate animals depicted.
(B) NP and IgD levels on CD4CD8 PI cells day 7 after NP-KLH immunization (first two panels). Small box insert outlines NPIgD. CD138
versus B220 on PICD4CD8NPIgD cells (second two panels). GL7 levels on CD138B220 NP-specific cells (third two panels). Controls
displayed in upper panels and prdm1flox/flox CD19Cre/ lower panels. Mean frequencies  SEM, n  3.
(C) Total NP-specific B cell numbers in spleen across day 0 (with serum transfer) and day 0, 7, and 14 after NP-KLH immunization (three mice/
group) total NP-specific cells (PICD4CD8NPIgD), CD138 cells (NP-specific and CD138B220/), B220 GL7(NP-specific and CD138-
B220GL7), B220CD79b (NP-specific and CD138B220CD79b).
(D) NP versus IgD levels on bone marrow harvested from day 7 immunized mice (first panels) mean frequencies  SEM, n  3 inserted. CD138
versus B220 on PICD4NPTlgD cells (second two panels). Total NP-specific cells in bone marrow (second panels) from two femurs mean 
SEM across three separate mice for day 0 (with serum transfer), day 0, 7, and 14 after NP-KLH immunization.
(E) Spleens from mice immunized with NP-KLH were stained for PNA (red) and CD138 (blue) 10, 12, 14, and 16 days after immunization.
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Figure 5. Upon Stimulation with LPS, prdm1/ B Cells Proliferate but Do Not Become PCs, Secrete Ig, or Induce S RNA or Protein
(A) Average number and SEM of viable cells during culture of B220 cells with LPS (prdm1/, open circles; control, filled diamonds). (B)
Splenocytes incubated with CFSE, then cultured with LPS for 2 days, were stained with B220. The CFSE intensity of B220 cells is shown
(prdm1/ B cells, solid line; control, dotted line; representative of four experiments). (C) Cell supernatants from LPS treated splenocytes were
assayed for secreted IgM and IgG3 by ELISA. Splenocytes cultured in LPS for 4 days were stained for B220 and CD138 (D) or analyzed by
ELISPOT to detect IgM secreting cells (E). (F) Cell lysates from splenocytes cultured for 4 days in LPS were analyzed by immunoblot to detect
M and S protein. By day 2, cultures are at least 90% B220 (data not shown). (G) Semiquantitative RT-PCR was used to detect M and
S mRNA in LPS treated B220 splenocytes.
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Figure 6. XBP-1 Is Not Induced or Processed in prdm1/ B Cells but Exogenous XBP-1 Is Not Sufficient to Rescue Defective CD138 Expression
and Ig Secretion in prdm1/ B Cells
(A) RNA was harvested from B220 splenocytes cultured in LPS for 4 days to be used for semiquantitative RT-PCR amplification of XBP-1
and GAPDH.
(B) Whole cell lysates from LPS treated splenocytes were immunoblotted to detect XBP-1 protein.
(C, D, and E) LPS treated splenocytes were infected with a retrovirus expressing YFP, YFP and Blimp-1, or YFP and XBP-1p. After 3 more
days of culture, B220YFP cells were analyzed for CD138 expression (C) and sorted for ELISPOT analysis to detect the number of IgM
secreting cells (D). RNA was also extracted from YFP cells for semiquantitative RT-PCR detection of XBP-1, DnaJ b9, and GAPDH (E).
studies that identified a large Blimp-1-dependent pro- necessary for cell division as well as induction of cdk
inhibitors p21 and p18 (Lin et al., 1997, 2000; Shaffer etgram that represses proliferation (Shaffer et al., 2002)
and with the fact that terminally differentiated PCs do al., 2002). Induction of p18 is particularly important,
since mice lacking p18 have a severe reduction in anti-not divide. The Blimp-1-regulated proliferation program
includes repression of c-myc, E2F-1, and other genes body-containing plasmacytoid cells (Tourigny et al.,
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2002). It is also consistent with hyperproliferation of B synthesis and subsequent UPR-dependent processing
of XBP-1 mRNA is a second, indirect, way that Blimp-1cells expressing a blocking form of Blimp-1 (Angelin-
Duclos et al., 2002). However, proliferation of prdm1/ regulates XBP-1.
Accordingly, we asked if failure to induce and processB cells does stop after 3 or 4 days of ex vivo culture
and we have not yet observed B cell lymphomas in XBP-1 mRNA was the sole reason prdm1/ B cells were
blocked for PC differentiation. Forced expression ofthe prdm1flox/floxCD19Cre/ mice. Thus, there appear to be
Blimp-1-independent, as well as Blimp-1-dependent XBP-1 (processed form) was unable to restore differenti-
ation and Ig secretion to prdm1/ B cells followingmechanisms for regulating proliferation of maturing B
cells. LPS treatment (Figure 6), demonstrating that Blimp-1 is
required to regulate genes in addition to XBP-1. Thus,Multiple mechanisms could be responsible for the de-
fect in Ig secretion in prdm1flox/floxCD19Cre/ mice. Previ- although Blimp-1 is important for regulation of XBP-1,
Blimp-1 and XBP-1 each regulate unique targets. Forous studies (Lin et al., 2002) showed that Blimp-1 re-
presses Pax5, relieving Pax5-dependent repression of example, Blimp-1 suppresses proliferation whereas pro-
liferation is normal in XBP-1/ B cells (Reimold et al.,J chain, Ig, and XBP-1 transcription (Shaffer et al., 1997;
Singh and Birshtein, 1993; Wallin et al., 1999). The 2001). Furthermore, Blimp-1 represses genes involved
in germinal center B cell functions (Shaffer et al., 2002)prdm1flox/floxCD19Cre/ mice confirm Blimp-1-dependent
induction of Ig (Figure 5; data not shown) and XBP-1 and prdm1flox/floxCD19Cre/ mice have abnormally large
germinal centers (Figures 3 and 4). However, in XBP-mRNA (Figure 6). B cells lacking Blimp-1 also failed to
generateS mRNA and protein (Figure 5). This suggests 1/ chimeras, germinal centers are normal (Reimold et
al., 2001). Finally, S mRNA levels are normal in XBP-a previously unknown requirement for Blimp-1 in the
developmentally regulated switch from membrane (M) 1/ B cells (Reimold et al., 2001). Therefore these func-
tions may be specifically dependent on Blimp-1. Withto secreted (S). Whether this switch depends on differ-
ential polyA site usage, splicing, or mRNA stability re- respect to XBP-1, few targets have been identified, but
Grp78 (Yoshida et al., 2001) and DnaJ (Lee et al., 2003)mains unresolved (Berberich and Schimpl, 1990; Pe-
terson and Perry, 1989; Phillips et al., 2001; Yan et al., may be unique direct targets of XBP-1.
1995) and it will be interesting to determine if Blimp-1
affects the activity of Cstf64 polyadenylation complexes A Role for Blimp-1 in Post-GC Memory Cells
(Takagaki and Manley, 1998) or factors such as U1A Primary exposure to antigen drives the development of
(Phillips et al., 2001) that affect mRNA processing and PCs and long-lived, antigen-experienced memory cells
stability. Alternatively, Blimp-1 could be required for an (MacLennan and Gray, 1986; McHeyzer-Williams, 2003;
event developmentally upstream of theM toS switch. McHeyzer-Williams and Ahmed, 1999). Upon resolving
Future studies using inducible Cre recombinase may be the cellular basis of the plasma cell defect in prdm1flox/flox
useful in addressing this issue. CD19Cre/ mice, we revealed an unexpected role for
The phenotype of the prdm1flox/floxCD19Cre/ mice es- Blimp-1 in B cell memory (Figures 3 and 4).
tablishes that Blimp-1 is required to drive the major The cellular organization of immune memory in vivo
portion of plasmacytic differentiation and that timely remains poorly understood. TH memory cells exist in at
arrest of cell cycle and induction of Ig secretion, two least two forms, referred to as “central” and “effector,”
critical components of this process, depend on Blimp-1. based on recirculation patterns, functional plasticity,
It rules out the existence of any other transcriptional and the rapidity of response to antigen recall (Lanzavec-
regulator with functions that can replace those of chia and Sallusto, 2002). B cell memory may also exist
Blimp-1 in this context. within these functional divisions (McHeyzer-Williams,
2003). CD138B220 memory B cells recirculate
through spleen and peripheral LNs (McHeyzer-WilliamsBlimp-1 and XBP-1
XBP-1 is the only transcription factor other than Blimp-1 et al., 2000), have greater proliferative capacity on adop-
tive transfer, but produce fewer PCs as expected of aknown to be uniquely required for plasma cell formation
and Ig secretion (Reimold et al., 2001). Since B cells central memory compartment. In contrast, CD79bB220
pre-plasma memory B cells appear mainly in the bonelacking XBP-1 express Blimp-1 normally (Reimold et al.,
2001), Blimp-1 is not sufficient for plasmacytic differenti- marrow (McHeyzer-Williams et al., 2000), differentiate
rapidly into PCs on antigen recall (McHeyzer-Williamsation without XBP-1. The defect in XBP-1 mRNA induc-
tion observed in prdm1/ B cells (Figure 6) is consistent et al., 2000), and may be capable of homeostatic conver-
sion to PCs in the absence of antigen (Bernasconi etwith Blimp-1 acting before XBP-1 and confirms earlier
data (Lin et al., 2002; Shaffer et al., 2002) showing al., 2002; O’Connor et al., 2002). However, they are not
PCs, do not secrete antibody spontaneously (McHeyzer-Blimp-1 induces XBP-1 mRNA. XBP-1 is also subject
to posttranscriptional regulation. The unfolded protein Williams et al., 2000), and do exhibit attributes of an
effector memory compartment. Our data show thatresponse (UPR) activates IRE1 endonuclease-depen-
dent processing of XBP-1 mRNA to generate mRNA Blimp-1 is required for the complete development of the
pre-plasma memory B cell compartment (Figures 3 andencoding a more active and stable form of XBP-1 (Calfon
et al., 2002; Lee et al., 2002; Yoshida et al., 2001), which 4). While other models are not ruled out, the simplest
explanation of the data is a linear progression of post-is required for PC differentiation (Iwakoshi et al., 2003).
Furthermore, Ig synthesis is necessary for the B cell germinal center development as outlined in Figure 7.
In this model, the GC reaction in a primary responseUPR that activates XBP-1 mRNA processing (Iwakoshi
et al., 2003). Since Blimp-1 is required for induction of produces B220 central memory B cells. These cells
appear rapidly in the marginal zones of the spleen (LiuS mRNA and protein (Figure 5), the induction of Ig
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to antigen recall (MacLennan and Gray, 1986). These
aberrant memory responses may be manifestations of
the same defect exhibited in the primary response, or
they may indicate incomplete development of the B220
central memory compartment itself. In either case, an
effective memory B cell response to antigen recall can-
not be mounted in the absence of Blimp-1. Thus, in
recall as well as primary responses, Blimp-1 is critical
for memory and PC development.
Experimental Procedures
Generation of prdm1Flox/FloxCD19Cre/ Mice
Exons 6-8 of prdm1 (with 5 LoxP site introduced by site-directed
mutagenesis), 8 kb of 5 sequence, 1 kb of 3 sequence, a neomycin
resistance gene (neo) flanked by LoxP sites, and an HSV-tk gene
were inserted into pKS after replacing its multiple cloning site (Figure
1). R1 embryonic stem (ES) cells were electroporated and cultured
using purified LIF (Hadjantonakis et al., 1999; Mereau et al., 1993;
Nagy et al., 1993). Fialuridine and neomycin were used for negative
and positive selection. Colonies were screened by PCR and South-
ern analysis for homologous recombination. Positive clones were
injected into C57/BL6 blastocysts. Chimera progeny were crossed
with mice expressing Cre ubiquitously to generate prdm1/ mice
(Lewandoski et al., 1997). Targeted ES clones were also transfected
with a Cre vector and screened for deletion of neo. Appropriate
clones were injected into C57/BL6 blastocysts. Chimera progeny
were crossed to each other, to prdm1/ mice, and to CD19Cre/
Figure 7. Model for Post GC B Cell Development mice (Rickert et al., 1997) to generate prdm1flox/-CD19Cre/ and
The gray box indicates stages that require Blimp-1. prdm1flox/floxCD19Cre/ mice. Prdm1flox/-CD19/, prdm1flox/floxCD19/,
prdm1flox/CD19Cre/, and prdm1-/CD19Cre/ were used as lit-
termate controls.
et al., 1988), where they may encounter residual antigen
Southern Blotsand accessory signals (Balazs et al., 2002) to develop
Genomic DNA was digested with EcoRI and hybridized with a 1 kbinto pre-plasma memory B cells and/or PCs. These pop-
KpnI/EcoRV fragment of prdm1 upstream of the deleted exons to
ulations have a propensity to home to the bone marrow detect endogenous, floxed, and deleted prdm1 as 15, 13.5, and 10
(Driver et al., 2001; McHeyzer-Williams et al., 2000) and kb bands respectively. The Cre recombinase gene was detected
by BamHI digestion and probing with Cre sequence to reveal 6.5persist in the absence of further antigen exposure
and 2.5kb bands. To determine the deletion efficiency of prdm1,(McHeyzer-Williams et al., 2000). Differentiation to PCs
DNA from purified B220 splenocytes of prdm1flox/-CD19Cre/,may also occur in the marrow (O’Connor et al., 2002).
prdm1flox/floxCD19Cre/, and control mice was analyzed.Localization and control of these changes remain specu-
lative, but identifying a role for Blimp-1 provides new
Immunization
insight into their relationship and the basis for further Prdm1flox/floxCD19Cre/ and littermate control mice, 7- to 12-week-old,
experimentation. were immunized intraperitoneally (IP) with either 25 g of
It is not clear if B220 NP B cells that persist in (4-hydroxy-3-nitrophenyl)acetyl (NP)-Ficoll in 0.1 ml of PBS or 100
g of NP-keyhole limpet hemocyanin (KLH) alum precipitated. Forthe absence of Blimp-1 are fully developed. They bind
a recall response, the same dose of NP-KLH was given at least 6equivalent levels of NP-APC under saturating conditions
weeks after the initial dose. For studies on NP-specific B cells, mice(Figure 4; Total NP B cells MFI 220  13 and 310 
were immunized IP with 400 g NP-KLH in Ribi adjuvant (Corixa).
12; B220 NP B cells MFI 280  20 and 290  16), For the memory response, 6 weeks after primary immunization mice
suggesting expression of similar affinity BCR in control were reimmunized with 400 g NP-KLH in Ribi adjuvant. Serum
and prdm1flox/floxCD19Cre/ mice (McHeyzer-Williams et transfer experiments used pooled immune serum from NP-immune
mice (3  day 14, 3  day 42, 5  day 5 memory) with 200 lal., 2000). Without the capacity to produce antibody, it
injected into the tail vein of naive C57BL/6 mice, 3 days and 24 hris difficult to test the function of Blimp-1-deficient B
before analysis.cells as bona fide memory cells on adoptive transfer
(McHeyzer-Williams et al., 2000). It will also be important
B Cell Culture
to evaluate the mutational status of the memory re- Splenocytes were suspended in NH4Cl buffer (Sigma) to lyse red
sponders in prdm1flox/floxCD19Cre/ mice to assess more blood cells and plated (106 cells/ml) in RPMI with 10% FCS,
directly the activity of the primary GC reaction. Blimp- 	-mercaptoethanol, and gentamicin. Stimulation was with 10 g/ml
of lipopolysaccharide (LPS) (Sigma).1-deficient B cells underwent rapid clonal expansion but
then exhibited the same block in pre-plasma memory B
B Cell Purificationcell and PC development as in the primary response
Freshly harvested splenocytes were incubated with APC conjugated(Figure 4). Interestingly, the selective pressures exerted

-mouse B220 (BD Pharmingen) in PBS with 1% BSA, 2 mM EDTA,by antigen rechallenge revealed even fewer residual PCs
and 2% FCS, washed, and incubated with goat 
-rat IgG1 mi-
than in the primary response. The exaggerated levels crobeads from Miltenyi. B220 cells were purified by positive selec-
of GL7 NP-specific cells at day 5 suggest extensive tion using a MACS column (Miltenyi) according to manufacturer’s




Retroviral vectors pGC-YFP and pGC-Blimp-1-YFP have been de-Whole cell lysates were subjected to SDS-polyacrylamide gel elec-
trophoresis (PAGE) and Western blotting as described (Lin et al., scribed (Piskurich et al., 2000). pGC-XBPp-YFP was generated by
the blunt ligation of XBP-1 cDNA from a plasmid that produces only2000). Antibodies were monoclonal 
-mouse Blimp-1 (Chang and
Calame, 2002), monoclonal 
-mouse 	-actin (Sigma), goat 
-mouse processed XBP-1 protein, pFLAG.XBP1p.CMV2, into the pGC-YFP
vector (Calfon et al., 2002).IgM (Roche), polyclonal rabbit 
-mouse XBP-1 (Santa Cruz Biotech-
nology), goat 
-mouse IgG1 conjugated to peroxidase (Roche), and

-goat IgG conjugated to peroxidase (Roche). For S and M blots, Retroviral Transduction
whole cell lysates were not centrifuged before SDS-PAGE. For The procedure for retrovirus vectors can be found at http://
XBP-1 blots, splenocytes were stimulated with 25 g/ml LPS and, www.stanford.edu/group/nolan/index.html. For pseudotyped virus,
for 1 hr before lysis in 2SDS loading buffer, treated with MG132 15 g of retroviral vector, 15 g of pSV---E-MLV, and 15 g of
(10 M, Sigma). VSV-G (pMD.G) was transfected into Phoenix cells. Viral superna-
tants were concentrated as described (Piskurich et al., 2000).
ELISA Splenic cells treated with LPS (25 g/ml) overnight were infected
To detect total IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA in unimmu- with concentrated virus stock (m.o.i. of 2–5). Three days after infec-
nized mice, NP-specific IgM, IgG1, IgG2a, and IgG3 in immunized tion, cells were analyzed by FACS. YFP cells were sorted by flow
mice (6 control and 6 prdm1flox/floxCD19Cre/ for primary response cytometry and used for ELISPOT analysis and semiquantitative
and 3 of each for recall) and secreted IgM and IgG3 in the cell RT-PCR.
supernatants of LPS stimulated splenocytes (3 days), enzyme-linked
immunosorbent assays (ELISA) were performed as previously de- Immunohistochemistry
scribed (Angelin-Duclos et al., 2002). Additionally, for NP-specific Spleens were processed and stained as described (Angelin-Duclos
Ig detection, plates were coated with NP(25)-BSA (Biosearch Tech- et al., 2000) using the biotin-avidin-peroxidase system to detect
nology) and for total IgA, with anti-IgA (BD Pharmingen). PNA and the alkaline phosphatase system to detect CD138.
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